6 ms·
I think I read (and I may be wrong) that the costs for the vaccines per dose were roughly as follows: Moderna: £45, Pfizer: £20, Oxford: £3, The Oxford one is
by agd 6y ago
I think I read (and I may be wrong) that the costs for the vaccines per dose were roughly as follows:
Moderna: £45,
Pfizer: £20,
Oxford: £3,
The Oxford one is also easier to store and transport.
- threeseed 6y agoOxford one is also going to be easier to manufacture given that it is based on existing technology. Many countries e.g. Australia are licensing the formula so this is an important aspect.
- singingfish 6y agothe mRNA style viruses will probably decrease in cost exponentially the same way that DNA sequencing and computer technology have dropped in price.
- starfallg 6y agoHowever, mRNA vaccines require low temperature storage and are in general harder to handle. This translates to additional cost in production, throughout the logistics chain and delivery.
- singingfish 6y agoI think it's likely that they'll need to be distributed frozen, but there's a lot that can be done researching preservatives. The the moderna vaccine is higher temperature than the pfveizer one for this reason.
- twic 6y agoPfizer are also working on a lyophilised, aka freeze-dried, version of their vaccine, which would not need to be stored at -80 C. This is from July [1], not sure if there is any more news: > But we also hope to have, as we always do in life cycle management, a new lyophilized formulated vaccine by -- within maybe a year after initial delivery such as fourth quarter 2021 and the lyophilized formulation could be stored in refrigerator. [1] https://s21.q4cdn.com/317678438/files/PFE-USQ_Transcript_2020-07-01.pdf https://s21.q4cdn.com/317678438/files/PFE-USQ_Transcript_202...
- Nitramp 6y agoI read the opposite - producing mRNA fragments at scale is supposedly cheaper than producing the inactivated vector viruses with the correct payload.
- intpx 6y agono real idea, but my guess is that its likely true that mRNA fragment production is cheaper, but inactivated vector manufacturing is already scaled up and out globally and mRNA is not-- existing labs around the world can maybe be more easily equipped to scale up production?
- londons_explore 6y agoConsidering most economies are losing ~£100/person/day by having everything shut, the cost is fairly irrelevant.
- bb123 6y agoNot for developing countries. And ultimately it is important for them to get vaccinated too, otherwise they will form a huge reservoir of COVID that will inevitably mutate and come back around to us.
- anoncake 6y agoThat is not how it works. The Spanish Flu hasn't "come back" yet and coronaviruses mutate a lot more slowly. It couldn't really come back anyway, because it's still there, downgraded to regular flu.
- umanwizard 6y ago> The Spanish Flu hasn't "come back" yet Yes it has, most recently in 2009. From Wikipedia: “ Well known outbreaks of H1N1 strains in humans include the 2009 swine flu pandemic, as well as the Spanish flu.”
- lorenzfx 6y agoI believe you misread the abstract. After reading the whole article, I believe it should be "include the `2009 swine flu pandemic`, as well as the `Spanish flu`".
- umanwizard 6y agoHow is that different from how you think I read it? The “Spanish flu” is the name of the 1918 outbreak of H1N1. There was also a major H1N1 outbreak in 2009.
- 6y ago
- pja 6y agoYes, the Oxford/AstraZeneca vaccine is much cheaper: https://www.bloomberg.com/news/articles/2020-11-22/astra-oxford-shot-is-key-to-escaping-pandemic-for-many-nations https://www.bloomberg.com/news/articles/2020-11-22/astra-oxf...